anidulafungin has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melo, RDCB; Mendes, FR; Rego, EM; Rocha, V; Silva, WFD; Velloso, EDRP | 1 |
| Candoni, A; Facchin, G; Fanin, R; Lazzarotto, D | 1 |
2 other study(ies) available for anidulafungin and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Assessing the impact of prophylactic anidulafungin during remission induction of acute myeloid leukemia - A propensity-score matching analysis.
Topics: Adult; Anidulafungin; Antifungal Agents; Fluconazole; Humans; Leukemia, Myeloid, Acute; Propensity Score; Remission Induction; Retrospective Studies | 2023 |
18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia.
Topics: Aged; Anidulafungin; Antifungal Agents; Drug Combinations; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney; Leukemia, Myeloid, Acute; Liver; Male; Mycoses; Nitriles; Positron-Emission Tomography; Pyridines; Spleen; Treatment Outcome; Triazoles | 2020 |